‌

ENCODIA, INC. SBIR Phase I Award, May 2021

A SBIR Phase I contract was awarded to Encodia Inc. in May, 2021 for $256,182.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

Overview Structured Data Issues Contributors

sbir.gov/node/2188671

Is a

SBIR/STTR Awards

SBIR/STTR Award attributes

SBIR/STTR Award Recipient

Encodia Inc.

Government Agency

Government Branch

National Institutes of Health

Award Type

SBIR0

Contract Number (US Government)

1R43GM142375-010

Award Phase

Phase I0

Award Amount (USD)

256,1820

Date Awarded

May 1, 2021

End Date

April 30, 2022

Abstract

ABSTRACT The goal of this proposal is to develop a highly-scalable technology for proteome analysis. The approach is broadly applicable and should greatly improve upon cost, sensitivity, usability, and throughput of proteomics and help democratize proteomics for Randamp;D research.NARRATIVE This proposal aims to develop technology for user-friendly, high-throughput analysis of proteins using both sample and analyte multiplexed assays. By making information about proteins more readily accessible, this technology has the potential to advance basic research in almost every area in molecular life sciences, as well as applied and clinical research, including drug target discovery and drug development.